Published by Josh White on 2nd October 2020
(Sharecast News) - Life sciences company OptiBiotix Health announced on Friday that one of its partners, Seed Health, has received US Food and Drug Administration authorisation for an investigational new drug (IND) application for 'DS-01'.
URL: http://www.digitallook.com/dl/news/story/31255863/...